Core Viewpoint - Abacus Life, Inc. is set to release its fourth quarter 2024 financial results on March 27, 2025, highlighting its role as a pioneering global alternative asset manager focused on longevity data and uncorrelated investment opportunities [1]. Company Overview - Abacus is a global alternative asset manager and market maker that specializes in uncorrelated financial products, utilizing proprietary longevity data and actuarial technology to purchase life insurance policies from consumers [3]. - The company manages nearly $3 billion in assets, making it the only publicly traded global alternative asset manager focused on lifespan-based financial products [4]. Upcoming Events - A conference call to discuss the financial results will take place at 5:00 pm Eastern Time on March 27, 2025, with a live webcast available on the investor relations website [2]. Growth and Innovation - Abacus is expanding its expertise in longevity and lifespan into new growth areas, aiming to revolutionize asset management and financial planning [4]. - The company offers ABL Wealth, which provides longevity-based wealth management platforms, and ABL Tech, a technology service for advanced data tracking and analysis [5].

Group 1 - Abacus Life, Inc. is set to release its fourth quarter 2024 financial results on March 27, 2025, after market close [1] - A conference call to discuss the financial results will take place at 5:00 pm Eastern Time on the same day, with a live webcast available on the investor relations website [2] - The company specializes in leveraging longevity data and actuarial technology to create uncorrelated investment opportunities, focusing on lifespan-based financial products [3][4] Group 2 - Abacus Life manages nearly $3 billion in assets, making it the only publicly traded global alternative asset manager in its niche [4] - The company is expanding its expertise in longevity and lifespan into new growth areas, aiming to revolutionize asset management and financial planning [4] - Abacus offers various platforms, including ABL Wealth for customized wealth management and ABL Tech for advanced data tracking and analysis [5]

Core Viewpoint - Abacus Life, Inc. has entered into warrant exchange agreements with holders of its publicly traded warrants, allowing them to exchange a total of 4,930,745 warrants for 1,134,071 shares of common stock, indicating a conversion ratio of 0.23 shares per warrant [1]. Company Overview - Abacus is a pioneering global alternative asset manager specializing in uncorrelated financial products, leveraging longevity data and actuarial technology to purchase life insurance policies from consumers seeking liquidity [3]. - The company manages nearly $3 billion in assets, including pending acquisitions, and is the only publicly traded global alternative asset manager focused on lifespan-based financial products [4]. Warrant Details - The Public Warrants were issued during the company's initial public offering, allowing holders to purchase up to 17,250,000 shares of common stock at an exercise price of $11.50 per share [2]. - Each redeemable whole Public Warrant entitles the holder to purchase one share of common stock at the specified price, with the warrants being a freestanding financial instrument traded on The Nasdaq Stock Market under the symbol "ABLLW" [2].

Core Viewpoint - Abacus Life, Inc. has rebranded FCF Advisors to Abacus FCF Advisors, enhancing its position in free cash flow investing and launching new investment products [1][2][5]. Group 1: Rebranding and New Products - The rebranding emphasizes Abacus's leadership in free cash flow investing and analytics, introducing the Abacus FCF Small Cap Leaders ETF (ticker: ABLS) [2]. - Management fee reductions of 5-10 basis points have been implemented across all ETFs, along with an 18-month fee waiver of 20 basis points on four ETFs [2][3]. Group 2: Investment Strategy and Performance - Abacus FCF Advisors has developed the Free Cash Flow Leaders Model, which is the basis for its quantitative investment process aimed at identifying profitable companies [2][6]. - The investment strategy focuses on high-conviction portfolios that prioritize prudent capital expenditure, low accruals, high cash flow margins, and strong asset turnover, historically leading to superior long-term capital growth [6]. Group 3: Company Overview and Market Position - Abacus Life is a pioneering global alternative asset manager with nearly $3 billion in assets under management, specializing in uncorrelated financial products [7][8]. - The company leverages longevity data and actuarial technology to create high-return asset classes that are uncorrelated to market fluctuations, targeting institutional investors [7][8].

Abacus Global Management (ABL) Conference January 22, 2025 01:00 PM ET Company Participants Robert Phillips - SVP, Investor Relations & Corporate AffairsDavid Jackson - IR Associate - Capital Markets Operator Right at the bottom of your screen. Feel free to type in any questions throughout the presentation and we can save time for Q and A at the end. But with that said, I'll pass it over to Rob. Robert Phillips Brandon, thanks very much. And thanks, everybody, for joining us. Really look forward to discussi ...

Group 1 - The investment approach focuses on long-term investments while incorporating short-term shorts to uncover alpha opportunities [1] - The analysis is based on bottom-up evaluation, emphasizing the fundamental strengths and weaknesses of individual companies [1] - The goal is to identify companies with solid fundamentals, sustainable competitive advantages, and growth potential [1]

Core Viewpoint - Abacus Life, Inc. (ABL) has been upgraded to a Zacks Rank 1 (Strong Buy), indicating a positive outlook on its earnings estimates, which is a significant factor influencing stock prices [1][2]. Earnings Estimates and Stock Price Movement - The Zacks rating system highlights the strong correlation between changes in earnings estimates and near-term stock price movements, driven by institutional investors who adjust their valuations based on these estimates [3][5]. - An increase in earnings estimates typically leads to higher fair value for a stock, prompting institutional investors to buy or sell, which subsequently affects stock prices [3]. Business Improvement Indicators - The upgrade in Zacks Rank for Abacus Life, Inc. suggests an improvement in the company's underlying business, which should encourage investors to drive the stock price higher [4][10]. - For the fiscal year ending December 2024, Abacus Life, Inc. is projected to earn $0.64 per share, reflecting a 23.1% increase from the previous year, with a 12.9% rise in the Zacks Consensus Estimate over the past three months [7]. Zacks Rank System Overview - The Zacks Rank system categorizes stocks into five groups based on earnings estimates, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988 [6]. - Only the top 5% of Zacks-covered stocks receive a 'Strong Buy' rating, indicating superior earnings estimate revisions, which positions Abacus Life, Inc. favorably for potential market-beating returns [8][9].

Core Viewpoint - Abacus Life, Inc. (ABL) shows potential for significant upside based on analysts' price targets, with a mean estimate of $14.38 indicating an 86.3% upside from the current price of $7.72 [2] Group 1: Price Target Insights - The consensus price target is often viewed with skepticism due to potential biases from analysts influenced by business relationships [3][5] - A tight clustering of price targets, indicated by a low standard deviation of $1.80, suggests strong agreement among analysts regarding the stock's price movement [6][13] - The lowest price target of $13 indicates a 68.4% increase, while the most optimistic target suggests a 120.2% increase to $17 [13] Group 2: Earnings Estimates and Analyst Sentiment - Recent upward revisions in earnings estimates, with a 3.6% increase in the Zacks Consensus Estimate, reflect growing analyst optimism about ABL's earnings prospects [7][11] - ABL holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for near-term upside [12] Group 3: Caution on Price Targets - Empirical research indicates that price targets often mislead investors more than they guide, suggesting that reliance solely on these targets can lead to disappointing returns [9][10]

Core Insights - Abacus Life, Inc. has completed the acquisition of Carlisle Management Company S.C.A., enhancing its position in the life settlement space with over $2 billion in assets under management [1][3] - The acquisition aligns with Abacus's strategy to drive long-term growth and diversify its alternative asset management offerings [1][3] - Jose Garcia, CEO of Carlisle, joins the Abacus Executive Leadership Team, indicating a commitment to leveraging synergies between the two companies [2][3] Company Overview - Abacus is a pioneering global alternative asset manager specializing in uncorrelated financial products, utilizing longevity data and actuarial technology to create high-return asset classes [4][5] - The company manages nearly $3 billion in assets, making it the only publicly traded global alternative asset manager focused on lifespan-based financial products [5] - Abacus is expanding its expertise into new growth areas, including ABL Wealth and ABL Tech, which focus on longevity-based wealth management and advanced data tracking services [6][7] Carlisle Management Company - Established in 2008, Carlisle is a leading global investment management firm licensed as an Alternative Investment Fund Manager in Luxembourg [8][10] - The firm is recognized for its transparent transactions and integrity in the life settlement industry, backed by over 60 years of combined investment experience [9][10] - Carlisle's management emphasizes maximizing investor returns and maintaining transparency within a regulated framework [10]

Core Viewpoint - Abacus Life, Inc. has received regulatory nonobjection from the Luxembourg CSSF for the acquisition of Carlisle Management Company, which will significantly enhance its asset management capabilities in the life settlement space [1][2]. Company Overview - Abacus Life is a pioneering global alternative asset manager specializing in uncorrelated financial products, leveraging longevity data and actuarial technology to create high-return investment opportunities [3][4]. - The company currently manages nearly $3 billion in assets, including pending acquisitions, and is the only publicly traded firm focused on lifespan-based financial products [4]. Acquisition Details - The acquisition of Carlisle Management Company is expected to add approximately $2.0 billion in assets under management to Abacus's ABL Wealth division [2]. - Carlisle has been a leader in the life settlement industry since 2008, known for its transparent transactions and integrity, and is licensed as an Alternative Investment Fund Manager under the CSSF [2][7]. Strategic Growth Areas - Abacus is expanding its expertise in longevity and lifespan into new growth areas, including: - ABL Wealth, which offers longevity-based wealth management platforms for financial advisors [5]. - ABL Tech, a technology service providing advanced real-time data tracking and analysis for various financial entities [5][6]. Industry Position - The acquisition of Carlisle is viewed as a major milestone for Abacus in expanding its global alternative asset management footprint, enhancing its position in the life settlement market [2].